Metronidazole - medicine shortage information

Back to CRITICAL Shortages     Back to ALL Shortages

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist. In most cases your doctor and pharmacist will know about the possible substitute medicines to continue your care.

In some cases the Supply Detail section below will provide information about the special arrangements that are in place for your health professional to prescribe or supply a substitute medicine. These may include reference to Special Access Scheme or "Under section 19a"

Product details Supply Impact Dates Further Details
Metronidazole Sandoz IV (Metronidazole 500 mg/ 100 mL Injection Solution Bag
AUST R: 118321
Active ingredients:
Metronidazole

Sponsor:
Sandoz Pty Ltd

Phone:
1800 634 500

Deletion from market:
20 Jul 2017

Status:
Discontinued

Patient impact:
Medium

Reason:
Discontinuation

DBL METRONIDAZOLE INTRAVENOUS INFUSION metronidazole 500mg/100mL solution for injection bag
AUST R: 129476
Active ingredients:
Metronidazole

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

From
20 Apr 2018
to
28 Jun 2019

Status:
Current

Patient impact:
Medium

Reason:
Manufacturing

Supply details:
Supply Of Substitute Medicine Approved Under Section 19A Of The Therapeutic Goods Act 1989

METRONIDAZOLE BAXTER metronidazole 500mg/100mL solution for injection bag
AUST R: 165164
Active ingredients:
Metronidazole

Sponsor:
Baxter Healthcare Pty Ltd

Phone:
1300302409

From
01 Jan 2019
to
15 Feb 2019

Status:
Current

Patient impact:
Critical

Availability:
Unavailable

Reason:
Manufacturing

TGA Management Actions:
10/01/19 An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.

METRONIDAZOLE-CLARIS metronidazole 500mg/100mL solution for injection vial
AUST R: 165161
Active ingredients:
Metronidazole

Sponsor:
Baxter Healthcare Pty Ltd

Phone:
1300302409

Deletion from market:
09 Jan 2019

Status:
Discontinued

Patient impact:
Critical

Availability:
Unavailable

Reason:
Other

TGA Management Actions:
10/01/19 An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-s19a-index and search for the active ingredient.